Essex Bio-Technology Ltd. (1061) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Modern Dental Group Ltd.

Shanghai INT Medical Instruments Co., Ltd.

Essex Bio-Technology Ltd.

Zylox-Tonbridge Medical Technology Co., Ltd.

Sisram Medical Ltd.

Acotec Scientific Holdings Ltd.

Shanghai Conant Optical Co., Ltd.

MicroPort CardioFlow Medtech Corp.

Peijia Medical Ltd.

Jenscare Scientific Co. Ltd.

Venus Medtech (Hangzhou), Inc.

Why is Essex Bio-Technology Ltd. ?

With ROE of 1.38%, it has a Very Expensive valuation with a 1.39 Price to Book Value

Over the past year, while the stock has generated a return of -20.79%, its profits have risen by 197.5%

Below par performance in long term as well as near term

Along with generating -20.79% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Essex Bio-Technology Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Essex Bio-Technology Ltd.

-100.0%

0.86

48.04%

Hang Seng Hong Kong

8.25%

0.41

19.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

24.35%

EBIT Growth (5y)

37.99%

EBIT to Interest (avg)

12.93

Debt to EBITDA (avg)

0.28

Net Debt to Equity (avg)

-0.18

Sales to Capital Employed (avg)

0.07

Tax Ratio

14.79%

Dividend Payout Ratio

22.16%

Pledged Shares

Institutional Holding

ROCE (avg)

20.02%

ROE (avg)

15.50%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

101

Industry P/E

Price to Book Value

1.39

EV to EBIT

84.87

EV to EBITDA

83.23

EV to Capital Employed

1.48

EV to Sales

17.48

PEG Ratio

Dividend Yield

2.32%

ROCE (Latest)

1.74%

ROE (Latest)

1.38%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

DIVIDEND PAYOUT RATIO(Y)

Highest at 24.29%

RAW MATERIAL COST(Y)

Fallen by 1.45% (YoY

CASH AND EQV(HY)

Highest at HKD 642.92 MM

DIVIDEND PER SHARE(HY)

Highest at HKD 2.5

OPERATING PROFIT(Q)

Highest at HKD 223.49 MM

OPERATING PROFIT MARGIN(Q)

Highest at 25.5 %

PRE-TAX PROFIT(Q)

Highest at HKD 213.82 MM

NET PROFIT(Q)

Highest at HKD 171.5 MM

EPS(Q)

Highest at HKD 0.29

-2What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at HKD 620.53 MM

Here's what is working for Essex Bio-Technology Ltd.

Operating Profit

Highest at HKD 223.49 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (HKD MM)

Operating Profit Margin

Highest at 25.5 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at HKD 213.82 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit

Highest at HKD 171.5 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS

Highest at HKD 0.29

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Cash and Eqv

Highest at HKD 642.92 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Dividend per share

Highest at HKD 2.5

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (HKD)

Dividend Payout Ratio

Highest at 24.29%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Fallen by 1.45% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Essex Bio-Technology Ltd.

Operating Cash Flow

Lowest at HKD 620.53 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)